NCT00984282 2018-09-13Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerBayerPhase 3 Completed417 enrolled 22 charts
NCT02114658 2017-08-03Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsBayerPhase 2 Completed18 enrolled